When shifting to the value-based care model, organizations should do a few things at a time instead of trying to do too much as once, said Dr Mark Friedberg, MD, MPP, Senior Natural Scientist, Director, Boston Office, RAND Corporation.
Transcript
How can practices shifting to value-based care models try to mitigate the effects of the requirements to alleviate some burnout?
This is the thing everyone wants to know. Payment reform is coming. How can we respond to it in a way that doesn’t deteriorate the work environment for our staff and hopefully that improves things for everybody: patients, staff, and the practices bottom line. So, I would say a couple of things. First, it is important not to try and bite off too much at one time. Try to have a plan for doing a couple of steps with certain payment models, and do that for a couple of years, let them gel, and then go on to the next thing. I think if you try to do bundle payment here, and ACO there, and medical home over here, that can be a recipe for too much going on all at once. The other key things that other systems have done a good job with is to try to wrangle all the different performance measures that are coming from all these different systems into something that makes sense to individuals within the practice. We have a pluralistic payment system, where there’s lots of different payers for any healthcare organization. If you’re dealing with let’s say a dozen different major payers and including, but not limited to, the government payers, and each one of them is coming in with what could easily be dozens of measures, you could, as an organization, be handling about 250 to even more than that different performance measures across all these payment programs. Passing those down directly to your frontline staff is going to be very difficult on them. It’s very hard for an individual human to respond to that many different incentives at once. So, one thing you can do at the top at the organization is say, “Look, we’re going to take all these measures down to a very small set of high priority measures for us this year, and we going to give clinicians and practice managers this small set that we’re just going to focus on, and let them work on those for a while, and maybe even strategically surrender on some measures that just don’t line up with the rest.” If you try to get them all, it’s a little bit difficult for the organization to respond in a rational manner.
Bringing Connectivity to the Specialty Pharmacy Workflow
May 2nd 2024In a session during the final full day of conference activity at AXS24, experts from CVS Health and Surescripts emphasized the need to simplify the prescribing workflow for specialty medication through proactive messaging, automation, and interoperability.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Industry Experts Tackle Specialty Drug Access Challenges for Employer Benefit Plans
May 2nd 2024Representatives from ICON plc and Symphony Health joined forces at AXS24 to discuss the challenges of managing high-cost specialty drugs and how they influence self-funded employer benefit plan design and employee access to specialty medications.
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Latest Advances and Updates of Treatment in the Real World at AUA
May 1st 2024The annual meeting of the American Urological Association (AUA) not only presents the newest therapies coming out but showcases the latest in how treatments are being used in the real world, said Stephen Freedland, MD, of Cedars Sinai.
Read More
Diving Deep Into Specialty Pharmacy: Insights and Forecasts From IQVIA’s Doug Long
May 1st 2024Doug Long, MBA, vice president of industry relations at IQVIA, covered a bevy of stakeholder investment–related topics in his presentation at AXS24 on trends in specialty pharmacy, chief among them challenges facing the industry, obesity medications, generics and biosimilars, new product launches, and the outlook for the US market.
Read More